Jenny Sun

Pfizer, Inc. Worldwide Medical and Safety
New York, New York, United States

Jenny Sun is an Epidemiologist in Safety Surveillance Research within Worldwide Medical and Safety at Pfizer. In this role, she is primarily responsible the conduct of post approval safety studies.

Before joining Pfizer, Jenny was a pharmacoepidemiology researcher and trainee at Harvard University. She received her PhD in the Program in Pharmacoepidemiology at Harvard T.H. Chan School of Public Health in 2020, where she conducted research with the Division of Pharmacoepidemiology at Brigham and Women’s Hospital. Jenny then completed a Postdoctoral Fellowship with the Department of Population Medicine at Harvard Pilgrim Health Care Institute, where she led drug safety studies within healthcare databases. Her research primarily focused on leveraging healthcare databases to evaluate medication use and safety, particularly in children and adolescents, and advancing methods in pharmacoepidemiology.

Disclosure information not submitted.

Presentation(s):

• Advanced Pharmacoepidemiology Methods: Mitigating Missing Data Concerns with External or Internal Subset Validation Populations

  Thursday, August 25, 2022
  2:00 PM – 6:00 PM CEST

• Initiation of Atenolol versus Methyldopa During Pregnancy and the Risk of Intrauterine Growth Restriction/small for Gestational Age

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST